Randomisation was stratified by best clinical response after completion of salvage chemotherapy ( complete response vs partial response vs stable disease ) and primary refractory Hodgkin 's lymphoma versus relapsed disease less than 12 months after completion of frontline therapy versus relapse 12 months or more after treatment completion .